SYK
Price
$377.30
Change
-$3.19 (-0.84%)
Updated
Jun 13 closing price
Capitalization
134.94B
47 days until earnings call
ZTEK
Price
$1.43
Change
-$0.06 (-4.03%)
Updated
Jun 13 closing price
Capitalization
120.63M
Interact to see
Advertisement

SYK vs ZTEK

Header iconSYK vs ZTEK Comparison
Open Charts SYK vs ZTEKBanner chart's image
Stryker
Price$377.30
Change-$3.19 (-0.84%)
Volume$876.07K
Capitalization134.94B
Zentek
Price$1.43
Change-$0.06 (-4.03%)
Volume$30.8K
Capitalization120.63M
SYK vs ZTEK Comparison Chart
Loading...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYK vs. ZTEK commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYK is a StrongBuy and ZTEK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (SYK: $377.30 vs. ZTEK: $1.43)
Brand notoriety: SYK and ZTEK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SYK: 65% vs. ZTEK: 57%
Market capitalization -- SYK: $134.94B vs. ZTEK: $120.63M
SYK [@Medical Specialties] is valued at $134.94B. ZTEK’s [@Medical Specialties] market capitalization is $120.63M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYK’s FA Score shows that 3 FA rating(s) are green whileZTEK’s FA Score has 0 green FA rating(s).

  • SYK’s FA Score: 3 green, 2 red.
  • ZTEK’s FA Score: 0 green, 5 red.
According to our system of comparison, SYK is a better buy in the long-term than ZTEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYK’s TA Score shows that 5 TA indicator(s) are bullish while ZTEK’s TA Score has 3 bullish TA indicator(s).

  • SYK’s TA Score: 5 bullish, 4 bearish.
  • ZTEK’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SYK is a better buy in the short-term than ZTEK.

Price Growth

SYK (@Medical Specialties) experienced а -1.72% price change this week, while ZTEK (@Medical Specialties) price change was -4.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.91%. For the same industry, the average monthly price growth was +1.14%, and the average quarterly price growth was +0.34%.

Reported Earning Dates

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-1.91% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than ZTEK($121M). ZTEK YTD gains are higher at: 52.128 vs. SYK (5.033). SYK has higher annual earnings (EBITDA): 4.93B vs. ZTEK (-11.39M). SYK has more cash in the bank: 3.05B vs. ZTEK (5.35M). ZTEK has less debt than SYK: ZTEK (1.28M) vs SYK (13B). SYK has higher revenues than ZTEK: SYK (20.5B) vs ZTEK (48.6K).
SYKZTEKSYK / ZTEK
Capitalization135B121M111,570%
EBITDA4.93B-11.39M-43,304%
Gain YTD5.03352.12810%
P/E Ratio42.99N/A-
Revenue20.5B48.6K42,181,070%
Total Cash3.05B5.35M57,108%
Total Debt13B1.28M1,018,809%
FUNDAMENTALS RATINGS
SYK vs ZTEK: Fundamental Ratings
SYK
ZTEK
OUTLOOK RATING
1..100
964
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
1477
SMR RATING
1..100
5697
PRICE GROWTH RATING
1..100
5340
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (22) in the Medical Specialties industry is somewhat better than the same rating for ZTEK (68) in the null industry. This means that SYK’s stock grew somewhat faster than ZTEK’s over the last 12 months.

SYK's Profit vs Risk Rating (14) in the Medical Specialties industry is somewhat better than the same rating for ZTEK (77) in the null industry. This means that SYK’s stock grew somewhat faster than ZTEK’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for ZTEK (97) in the null industry. This means that SYK’s stock grew somewhat faster than ZTEK’s over the last 12 months.

ZTEK's Price Growth Rating (40) in the null industry is in the same range as SYK (53) in the Medical Specialties industry. This means that ZTEK’s stock grew similarly to SYK’s over the last 12 months.

SYK's P/E Growth Rating (22) in the Medical Specialties industry is significantly better than the same rating for ZTEK (100) in the null industry. This means that SYK’s stock grew significantly faster than ZTEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SYKZTEK
RSI
ODDS (%)
Bearish Trend 3 days ago
55%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 27 days ago
56%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMUAX14.66N/A
N/A
Federated Hermes Muni and Stock Adv A
MIQPX11.80N/A
N/A
Morgan Stanley Inst International Eq R6
BSCAX17.33N/A
N/A
Brandes Small Cap Value A
JLVZX19.98-0.21
-1.04%
JPMorgan Large Cap Value R2
RYAEX117.51-2.39
-1.99%
Rydex Europe 1.25x Strategy A

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with ISRG. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-0.84%
ISRG - SYK
66%
Closely correlated
-0.16%
MMSI - SYK
56%
Loosely correlated
-0.65%
A - SYK
56%
Loosely correlated
-1.54%
STE - SYK
55%
Loosely correlated
-0.44%
MDT - SYK
53%
Loosely correlated
-1.38%
More

ZTEK and

Correlation & Price change

A.I.dvisor tells us that ZTEK and SYK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTEK and SYK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTEK
1D Price
Change %
ZTEK100%
-4.03%
SYK - ZTEK
22%
Poorly correlated
-0.84%
PRCT - ZTEK
22%
Poorly correlated
-0.87%
VNRX - ZTEK
21%
Poorly correlated
+6.67%
SNN - ZTEK
21%
Poorly correlated
-2.39%
STSS - ZTEK
21%
Poorly correlated
-7.47%
More